Pancreatic Cancer Chronic inflammation from chronic pancreatitis can increase your risk of pancreatic cancer
Brito, of the Mayo Clinic, looked at data from January 1, 2014 to December 31, 2021 on 351,913 patients who started taking either a GLP-1 drug, a sodium-glucose cotransporter 2 inhibitor (SGLT2i) like Jardiance or Farxiga, dipeptidyl peptidase-4 inhibitor (DPP4i) like Januvia and Onglyza, or a sulfonylurea such as Glucotrol
Therapeutic plasma exchange - an emerging treatment modality in patients with neurologic and non-neurologic diseases
This dual action often produces stronger appetite suppression and metabolic effects, making tirzepatide particularly effective for patients whose semaglutide response has plateaued
Studies following major weight loss have documented that changes in perceived attractiveness, social visibility, or interpersonal roles can introduce new tensions or amplify pre-existing patterns [79,80,81]
They act like messengers in the body, carrying instructions to your cells
